BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7627127)

  • 21. S-carbobenzoxyglutathione: a competitive inhibitor of mammalian glyoxalase II.
    Hsu YR; Norton SJ
    J Med Chem; 1983 Dec; 26(12):1784-5. PubMed ID: 6644749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maillard reactions in lens proteins: methylglyoxal-mediated modifications in the rat lens.
    Shamsi FA; Sharkey E; Creighton D; Nagaraj RH
    Exp Eye Res; 2000 Mar; 70(3):369-80. PubMed ID: 10712823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate.
    Cacciatore I; Caccuri AM; Cocco A; De Maria F; Di Stefano A; Luisi G; Pinnen F; Ricci G; Sozio P; Turella P
    Amino Acids; 2005 Nov; 29(3):255-61. PubMed ID: 16082503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glyoxalase activities in human tumour cell lines in vitro.
    Ayoub F; Zaman M; Thornalley P; Masters J
    Anticancer Res; 1993; 13(1):151-5. PubMed ID: 8476206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glyoxalase II in Saccharomyces cerevisiae: in situ kinetics using the 5,5'-dithiobis(2-nitrobenzoic acid) assay.
    Martins AM; Cordeiro C; Freire AP
    Arch Biochem Biophys; 1999 Jun; 366(1):15-20. PubMed ID: 10334858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic tobacco plants overexpressing glyoxalase enzymes resist an increase in methylglyoxal and maintain higher reduced glutathione levels under salinity stress.
    Yadav SK; Singla-Pareek SL; Reddy MK; Sopory SK
    FEBS Lett; 2005 Nov; 579(27):6265-71. PubMed ID: 16253241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor.
    Thornalley PJ
    Crit Rev Oncol Hematol; 1995 Aug; 20(1-2):99-128. PubMed ID: 7576201
    [No Abstract]   [Full Text] [Related]  

  • 28. Dinitrosyl-dithiol-iron complexes, nitric oxide (NO) carriers in vivo, as potent inhibitors of human glutathione reductase and glutathione-S-transferase.
    Keese MA; Böse M; Mülsch A; Schirmer RH; Becker K
    Biochem Pharmacol; 1997 Dec; 54(12):1307-13. PubMed ID: 9393673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of mammalian glyoxalase I (lactoylglutathione lyase) by N-acylated S-blocked glutathione derivatives as a probe for the role of the N-site of glutathione in glyoxalase I mechanism.
    Al-Timari A; Douglas KT
    Biochim Biophys Acta; 1986 Mar; 870(1):160-8. PubMed ID: 3947646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Putative role of antioxidant enzymes and glyoxalases in carcinogenesis.
    Liotti FS; Menghini AR; Guerrieri P; Mariucci G; Armellini R
    Bull Cancer; 1993 Jan; 80(1):62-8; discussion 68-9. PubMed ID: 8204920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of glyoxalase II from bovine liver mitochondria.
    Talesa V; Principato GB; Norton SJ; Contenti S; Mangiabene C; Rosi G
    Biochem Int; 1990; 20(1):53-8. PubMed ID: 2328024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition by glutathione derivatives of bovine liver glyoxalase II (hydroxyacylglutathione hydrolase) as a probe of the N- and S-sites for substrate binding.
    Al-Timari A; Douglas KT
    Biochim Biophys Acta; 1986 Mar; 870(2):219-25. PubMed ID: 3955057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glyoxalase II does not support methylglyoxal detoxification but serves as a general trypanothione thioesterase in African trypanosomes.
    Wendler A; Irsch T; Rabbani N; Thornalley PJ; Krauth-Siegel RL
    Mol Biochem Parasitol; 2009 Jan; 163(1):19-27. PubMed ID: 18848584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Explaining the inhibition of glyoxalase II by 9-fluorenylmethoxycarbonyl-protected glutathione derivatives.
    Yang KW; Sobieski DN; Carenbauer AL; Crawford PA; Makaroff CA; Crowder MW
    Arch Biochem Biophys; 2003 Jun; 414(2):271-8. PubMed ID: 12781779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ascorbic and dehydroascorbic acid on glyoxalase enzyme system.
    Liotti FS; Principato GB; Talesa V
    Int J Vitam Nutr Res; 1985; 55(2):193-5. PubMed ID: 4019075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells.
    Sakamoto H; Mashima T; Sato S; Hashimoto Y; Yamori T; Tsuruo T
    Clin Cancer Res; 2001 Aug; 7(8):2513-8. PubMed ID: 11489834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione adducts of helenalin and 11 alpha,13-dihydrohelenalin acetate inhibit glutathione S-transferase from horse liver.
    Schmidt TJ
    Planta Med; 2000 Mar; 66(2):106-9. PubMed ID: 10763580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of glyoxalase I: the first low-nanomolar tight-binding inhibitors.
    More SS; Vince R
    J Med Chem; 2009 Aug; 52(15):4650-6. PubMed ID: 19610604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcoming cytostatic-drug resistance is also a strong inhibitor of glyoxalase I.
    Johansson AS; Ridderström M; Mannervik B
    Mol Pharmacol; 2000 Mar; 57(3):619-24. PubMed ID: 10692504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the glyoxalase pathway in human brain microvascular endothelium: effects of troglitazone and tertiary butylhydroperoxide.
    Wu L; Davies GF; Roesler WJ; Juurlink BH
    Endothelium; 2002; 9(4):273-8. PubMed ID: 12572858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.